View This Report »
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...
The global colorectal cancer diagnostics and therapeutics market is expected to grow at a CAGR of around 6% during the forecast period 2016-2021. The market is estimated to be valued at USD 8000 million ...
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. - ...